Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series

OBJECTIVE: Assessement of the responder and non-responder rate to consecutive monoclonal CGRP-antibody (CGRP-mAb) treatment, the presence of side effects, analysis of predictors of response and loss-of-effectiveness evaluation over time. METHODS: We conducted a retrospective analysis including 171 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaltseis, Katharina, Filippi, Vera, Frank, Florian, Eckhardt, Christine, Schiefecker, Alois, Broessner, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142255/
https://www.ncbi.nlm.nih.gov/pubmed/37118682
http://dx.doi.org/10.1186/s12883-023-03203-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142255/
https://www.ncbi.nlm.nih.gov/pubmed/37118682
http://dx.doi.org/10.1186/s12883-023-03203-9

Ejemplares similares